PA
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.526
Exchange
XNAS - Nasdaq
1.5 B
Last period Assets ,USD
785%
Assets has increased in 5 years
What is Assets ?
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
See also Pacific Biosciences
Company Analysis
PACB valuation, rating, competitors, insights and company profile
Eyestock Rating
PACB financial analysis by Eyestock methodology
Valuation
PACB valuation using historical relative method
Statements
PACB Income Statements, Balance Sheet and Cash Flow Statements
Dividends
PACB dividend yield and annual dividend
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
Pacific Biosciences`s Assets for the period ended 2024-06-30 are 1.5 B USD
